Topics

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Adverse effects of COVID-19 vaccines and measures to prevent them
Alternate mechanisms of mRNA vaccine toxicity: which one is the main culprit?
Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case Report
Antiviral treatments [Molnupiravir] lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients
Commentary from Dr. David Bauer of the Francis Crick Institute
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
COVID-19 vaccines – An Australian Review
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice
Homology between SARS CoV-2 and human proteins
Hybrid and herd immunity 6 months after SARS-CoV-2 exposure among individuals from a community treatment program
Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAs
mRNA Vaccine Toxicity
SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly
Strategies for the Management of Spike Protein-Related Pathology
Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam
Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns
Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation
1014